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2H-pyranAbstract In this study, we describe a green and simple procedure for the synthesis of steroidal 2H-
pyrans 4–6 using chitosan as an eco-friendly heterogeneous catalyst. The synthesized compounds
were characterized by IR, 1H NMR, 13C NMR, MS and analytical data. These compounds were
tested in vitro against two cancer cell lines [HeLa (cervical) and Jurkat (leukemia)] and one normal
cell line (PBMC). The compounds exhibited moderate to good activity against the two human can-
cer cell lines and were less toxic against the non-cancer cell line. In addition, the synthesized com-
pounds were tested for their in vitro antioxidant activity by 1,1-diphenylpicrylhydrazyl method in
which compounds 4 and 6 exhibited good antioxidant activity. This study provided a new molecular
scaffold for the further development of anticancer as well as antioxidant agents.
ª 2013 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Green chemistry can be recognized as a pioneering research,
which widely reports intrinsic atom economy, energy savings,
waste reduction, easy work ups and the avoidance of hazard-
ous chemicals (Kumar et al., 2012). The progress of a simple
and eco-friendly reaction protocol for the synthesis of highlyfunctionalized compound libraries of medicinal motifs is an
attractive area of investigation in both academia and the phar-
maceutical industry (Domling, 2006). Chitosan is readily pre-
pared via aqueous alkali promoted hydrolysis of chitin.
Being hydrophilic and possessing basic moieties (Bader and
Birkholz, 1996), chitosan has been utilized as a heterogeneous
eco-friendly basic catalyst for reactions carried out in protic
medium (Gomha and Riyadh, 2009). Steroids are an impor-
tant class of natural products which have high capability to
penetrate cells and bind to nucleus and membrane receptors.
They include great variations in structure and play a very
important role in life (Festi et al., 2007; Ifere et al., 2009).
The investigation of modiﬁed steroid derivatives condensed
with different heterocyclic rings has drawn great attention
2 Shamsuzzaman et al.(El-Far et al., 2009). Pyrans and their derivatives constitute an
important class of organic compounds due to their attractive
pharmacological and biological properties (Green et al.,
1995; Nemouchi et al., 2012). They are widely used as antico-
agulant, anticancer, diuretic, spasmolitic and antianaphylactin
agents (Bonsignore et al., 1993) and can be used as cognitive
enhancers for the treatment of neurodegenerative disease,
including Alzheimer’s disease, Huntington’s disease, Parkin-
son’s disease and Down’s syndrome as well as for the treat-
ment of schizophrenia and myoclonus (Konkoy et al., 2001).
Our group has been involved in the study of the structural
requirements of steroids to display biological activities, specif-
ically, on heterosteroid studies involving in vitro anticancer
and antimicrobial evaluation of newly synthesized steroids
and analysis of structure–activity relationships. In light of
our interest to develop environmentally benign processes to
synthesize heterosteroids (Shamsuzzaman et al., 2013a), we
here report green synthesis, in vitro anticancer and antioxidant
activities of steroidal 2H-pyrans.
2. Experimental
2.1. Materials and methods
All chemicals were purchased from Sigma–Aldrich (India) and
Merck (India) as analytical grade. Chitosan was supplied by
Sigma–Aldrich (India) as practicle grade. The solvents were
puriﬁed prior to use. Melting points were determined on a
Koﬂer apparatus in degree Celsius. The IR spectra were re-
corded on KBr pellets with Interspec 2020 FT-IR
Spectrometer SpectroLab and values are given in cm1. 1H
and 13C NMR spectra were run in CDCl3 on a JEOL Eclipse
(400 MHz) instrument with TMS as internal standard and val-
ues are given in ppm (d). Elemental analyses of all the new
compounds were recorded on a Perkin Elmer 2400 CHN Ele-
mental Analyzer. Mass spectra were recorded on a JEOL SX
102/DA- 6000 Mass Spectrometer. Thin layer chromatography
(TLC) plates were coated with silica gel G and exposed to io-
dine vapors to check the homogeneity as well as the progress of
reaction. Sodium sulfate (anhydrous) was used as a drying
agent.
2.2. General method for the synthesis of steroidal 2H-pyran
derivatives (4–6)
A mixture of steroidal a, b-unsaturated ketone 1, 2 or 3
(1 mmol) and ethyl acetoacetate (1 mmol) in 30 mL methanol
was reﬂuxed for 13–16 h in the presence of chitosan
(20 mol%). The progress of the reaction was monitored by
TLC. After completion of the reaction, chitosan was removed
by ﬁltration and the ﬁltrate was taken in ether, washed with
water, dried over anhydrous sodium sulfate and concentrated
in vacuo giving a residue which was recrystallized from ethanol
affording products 4, 5 or 6.
2.2.1. 3b-Acetoxy-20-oxo-30-acetyl-30,60-dihydro-cholest-6-eno
[5, 7- d e ] 2H-pyran (4)
White powder, Mol. Wt. 526.750, yield 73% (0.384 gm), m.p.
176–178 C, IR (KBr) m: 1743 (3b-AcO), 1715 (CHCOCH3),
1673 (OCOCH3), 1622 (C‚C), 1245 (C–O).
1H NMR(400 MHz, CDCl3) d: 5.21 (1H, s, C6H), 4.80 (1H, m,
C3a-H, W ½= 16 Hz), 3.21 (1H, s, C03H), 2.03 (3H, s,
OCOCH3), 2.01 (3H, s, CHCOCH3), 1.20 (3H, s, C13–CH3),
1.14 (3H, s, C10–CH3), 1.02 (3H, t, CH3), 0.97 & 0.82 (other
methyl protons). 13C NMR (100 MHz, CDCl3) d: 170.1 (3b-
AcO), 168.3 (CHCOCH3), 163.5 (OCOCH), 157.2 (C7), 112.1
(C6), 72.2 (C3), 64.3 (C
0
3) 48.4 (C17), 41.4 (C12), 40.1 (C11),
39.4 (C24), 38.5 (C10), 35.3 (C22), 34.2 (C9), 32.3 (C5), 31.4
(C13), 30.1 (C1), 29.2 (C20), 28.3 (C25), 28.2 (C8), 28.1
(OCOCH3), 27.2 (C4), 25.4 (C23), 24.1 (C2), 22.3 (C
00
2), 22.2
(C26), 22.1 (C27), 21.3 (C14), 21.2 (C15), 21.1 (C16), 20.1 (C18),
18.4 (C21), 17.3 (C19). Anal. Calcd for C33H50O5: C, 75.25,
H, 9.57. Found C, 75.21, H, 9.54. MS: m/z= (M+) 526, 365
(base peak).
2.2.2. 3b-Chloro-20-oxo-30-acetyl-30,60-dihydro-cholest-6-eno
[5, 7- d e ] 2H-pyran (5)
White powder, Mol. Wt. 503.160, yield 71% (0.357 gm), m.p.
165–167 C, IR (KBr) m: 1718 (CHCOCH3), 1675 (OCOCH),
1620 (C‚C), 1243 (C–O), 745 (C3–Cl).
1H NMR (400 MHz,
CDCl3) d: 5.40 (1H, s, C6H), 3.81 (1H, m, C3a-H, W
½= 17 Hz), 3.10 (1H, s, C03H), 2.01 (3H, s, CHCOCH3),
1.20 (3H, s, C13–CH3), 1.14 (3H, s, C10–CH3), 1.02 (3H, t,
CH3), 0.97 & 0.82 (other methyl protons).
13C NMR
(100 MHz, CDCl3) d: 167.1 (CHCOCH3), 161.3 (OCOCH),
159.4 (C7), 114.4 (C6), 64.5 (C
0
3), 52.1 (C3), 48.2 (C17), 41.3
(C12), 40.3 (C11), 39.1 (C24), 38.2 (C10), 35.3 (C22), 34.6 (C9),
32.4 (C5), 31.2 (C13), 30.3 (C1), 29.2 (C20), 28.2 (C25), 28.3
(C8), 27.1 (C4), 25.2 (C23), 24.3 (C2), 22.3 (C
00
2), 22.2 (C26),
22.1 (C27), 21.3 (C14), 21.2 (C15), 21.1 (C16), 20.3 (C18), 18.1
(C21), 17.2 (C19). Anal. Calcd for C31H47ClO3: C, 74.00, H,
9.42. Found C, 74.02, H, 9.44. MS: m/z= [M+] 502/ 504,
394 (base peak).
2.2.3. 20-Oxo-30-acetyl-30,60-dihydro-cholest-6-eno [5, 7- d e ]
2H-pyran (6)
White powder, Mol. Wt. 468.710, yield 70% (0.327 gm), m.p.
170–172 C, IR (KBr) m: 1720 (CHCOCH3), 1677 (OCOCH),
1621 (C‚C), 1246 (C–O). 1H NMR (400 MHz, CDCl3) d:
5.31 (1H, s, C6H), 3.31 (1H, s, C
0
3H), 2.01 (3H, s, CHCOCH3),
1.20 (3H, s, C13–CH3), 1.14 (3H, s, C10–CH3), 1.02 (3H, t,
CH3), 0.97 & 0.82 (other methyl protons).
13C NMR
(100 MHz, CDCl3) d: 165.1 (OCOCH3), 160.3 (OCOCH),
158.1 (C7), 116.3 (C6), 65.3 (C
0
3), 48.3 (C17), 41.4 (C12), 40.4
(C11), 39.1 (C24), 38.3 (C10), 35.3 (C22), 34.4 (C9), 32.3 (C5),
31.1 (C13), 30.3 (C1), 29.3 (C20), 28.2 (C25), 28.1 (C8), 27.3
(C4), 25.2 (C23), 25.1 (C3), 24.1 (C2), 22.3 (C
00
2), 22.2 (C26),
22.1 (C27), 21 (C14), 21 (C15), 21 (C16), 20 (C18), 18 (C21), 17
(C19). Anal. Calcd for C31H48O3: C, 79.44, H, 10.32. Found
C, 79.42, H, 10.34. MS: m/z= (M+) 468, 400 (base peak).2.3. In vitro anticancer activity
2.3.1. Cell lines and culture conditions
Human cancer cell lines HeLa (cervical) and Jurkat (leukemia)
(obtained from NCCS Pune, Maharashtra) were taken for the
study. The tumor cells and normal cells were maintained in
RPMI 1640 culture medium supplemented with 10% heat-
inactivated fetal calf serum (FCS).
Table 1 Comparison of the efﬁciency of chitosan on the
model reaction.a
Entry Catalysts Time (h) Yield of 4 (%)b
1 Piperidine 20 60
2 NaOMe 32 43
3 Pyridine 25 50
4 Triethylamine 36 34
5 Chitosan 16 73
a Reaction conditions: 3b-acetoxy-cholest-5-en-7-one (1 mmol),
ethyl acetoacetate (1 mmol) and different catalysts (5 mol%) in
30 mL methanol.
b Yields are related to isolated pure products.
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Fresh blood (20–15 mL) was kindly provided by the Blood
Bank Jawahar Lal Nehru Medical College, AMU Aligarh.
The blood sample was diluted with the same volume of phos-
phate buffered saline (PBS) (1.5 KH2PO4, 6.5 Na2HPO4, 137
NaCl, and 2.7 mM KCl; pH 7.4). Then the diluted blood sam-
ple was carefully layered on Ficoll-Histopaque. The mixture
was centrifuged at 400g for 30 min at 20–22 C. The undis-
turbed lymphocyte layer was carefully transferred out. The
lymphocyte was washed and pelleted down with 3 v of PBS
for twice and resuspended RPMI-1640 media with antibiotic
and antimycotic solution 10%, v/v FCS. Cell counting was
performed to determine the PBMC cell number with equal vol-
ume of trypan blue (Yeap et al., 2007).
2.3.3. Cell viability assay (MTT)
The in vitro anticancer activity was measured using the
3-(4,5-dimethylthizao1-2-y1)-2,5-diphenyltetrazolium bromide
(MTT) assay. The assay was carried out according to the
known protocol (Shamsuzzaman et al., 2013b). Exponentially
growing cells were harvested and plated in 96-well plates at a
concentration of 1 · 104 cells/well. After 24 h incubation at
37 C under a humidiﬁed 5% CO2 to allow cell attachment,
the cells in the wells were respectively treated with target com-
pounds at various concentrations for 48 h. The concentration
of DMSO was always kept below 1.25%, which was found
to be non-toxic to the cells. A solution of MTT, was prepared
at 5 mg/mL in PBS. 20 lL of this solution was added to each
well. After incubation for 4 h at 37 C in a humidiﬁed incuba-
tor with 5% CO2, the medium/MTT mixtures were removed,
and the formazan crystals formed by the mitochondrial
dehydrogenase activity of vital cells were dissolved in 100 lL
of DMSO per well. The absorbance of the wells was read with
a microplate reader (Bio-Rad Instruments) at 570 nm. Effects
of the drug cell viability were calculated using a cell treated
with DMSO as control.
2.3.4. Data analysis
Cell survival was calculated by using the formula: Survival
(%) = [(absorbance of treated cells  absorbance of culture
medium)/(absorbance of untreated cells  absorbance of cul-
ture medium)] · 100 (Shamsuzzaman et al., 2013b). The
experiment was done in triplicate and the inhibitory concen-
tration (IC) values were calculated from a dose response
curve. IC50 is the concentration in ‘lM’ required for 50%
inhibition of cell growth as compared to that of control.
IC50 values were determined from the linear portion of the
curve by calculating the concentration of agent that reduced
absorbance in treated cells, compared to control cells, by
50%. Evaluation is based on mean values from three indepen-
dent experiments, each comprising at least six microcultures
per concentration level.
2.4. Antioxidant activity
Steroidal 2H-pyran derivatives 4–6 were tested for their anti-
oxidant property by 1,1-diphenylpicrylhydrazyl (DPPH) meth-
od (Lone et al., 2013). Drug stock solution (1 mg/mL) was
diluted to ﬁnal concentration of 2, 4, 6, 8, 10 and 12 mg/mL
in methanol. Methanolic DPPH solution (1 mL, 0.3 mmol)
was added to 3.0 mL of drug solution of different concentra-tions. The tube was kept at an ambient temperature for
30 min and the absorbance was measured at 517 nm. The scav-
enging activity was calculated by the following formula:
½% inhibition ¼ ½ðAControl  ASample=AControl  100
where AControl is the absorbance of the L-ascorbic acid (Stan-
dard) and ASample is the absorbance of different compounds.
The methanolic DPPH solution (1 mL, 0.3 mM) was used as
control.
3. Results and discussion
3.1. Chemistry
The synthesis of steroidal 2H-pyran derivatives 4–6 involves
the use of 3b-acetoxy-cholest-5-en-7-one (1), 3b-chloro-cho-
lest-5-en-7-one (2) and cholest-5-en-7-one (3), as starting mate-
rials which have been synthesized by the literature method
(Dauben and Takemura, 1953). The present strategy of synthe-
sizing compounds 4–6 by green method involves the reaction
of steroidal a, b-unsaturated ketones 1–3 with ethyl acetoace-
tate in the presence of chitosan as an eco-friendly heteroge-
neous catalyst. The catalytic system is inﬂuenced by various
reaction parameters, such as amount of the catalyst employed,
effect of catalyst and solvent system. Therefore, in our initial
investigation to establish the optimum reaction conditions
3b-acetoxy-cholest-5-en-7-one (1) and ethyl acetoacetate in
methanol were selected as model substrates. We have applied
a wide range of basic catalysts such as piperidine, NaOMe,
pyridine, triethylamine and chitosan to improve the yield for
the speciﬁc synthesis of derivatives.
As shown in Table 1, chitosan is superior to other catalysts
in terms of time and yield. We then tried to screen the reaction
in various organic solvents in order to optimize the solvent
using chitosan as catalyst. It is noteworthy to mention that
the polar solvents (methanol and ethanol) afforded better yield
than the non-polar ones and the best result was obtained in
methanol as we can see in Table 2.
We then tried to optimize the catalyst load for the forma-
tion of steroidal 2H-pyrans and we found that 20 mol% of
the catalyst was sufﬁcient to get optimum yields in less reaction
time. Use of more than 20 mol% of the catalyst does not have
any profound effect on the reaction rate as well as the yield.
This result may be attributed to the coagulation of the catalyst
which decreased the effective surface area of the catalyst
(Bhattacharyya et al., 2012). Our study revealed that even after
Table 2 Effect of various solvents on the model reaction.
Entry Solvent Time(h) Yield of 4 (%)a
1 Acetonitrile 26 30
2 Methanol 16 73
3 DMSO 22 40
4 Toluene 34 22
5 Ethanol 20 60
a Yields are related to isolated pure products.
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4 Shamsuzzaman et al.ﬁve cycles, the catalyst was able to carry out the reaction offer-
ing almost the same catalytic activity. In order to investigate
the scope of this reaction, a variety of three steroidal com-
pounds were subjected to this reaction and all the reactions
proceeded smoothly and the reaction was completed within
13–16 h to afford the products 4–6 in good yields (70–73%).
(Scheme 1).
The spectral studies of products were found in good agree-
ment with the proposed structures for steroidal 2H-pyrans
4–6. In the IR spectra the absorption bands in the range
1715–1720 cm1 show the presence of CHCOCH3 while the
absorption bands at 1673–1677 cm1 conﬁrm the presence of
OCOCH. The weak absorption band in the range 1620–
1622 cm1 conﬁrms the presence of (C‚C). In 1H NMR study
of compounds 4–6 the presence of sharp singlet at d 5.21–5.40
was assigned to oleﬁnic proton (C6–H) while singlet at d 3.10–
3.31 integrated for one proton of C03H. In
13C NMR study, the
signals at d 165.1–168.3 conﬁrm the presence of OCOCH3
while the signals at d 160.3–163.5 conﬁrm the presence of
OCOCH. Finally the mass spectra data of compounds showed
molecular ion peaks [M+] at m/z: 526, 502/504 and 468 for 4, 5
and 6, respectively. All these data conﬁrmed the formation of
desired products. The stereochemical assignation of the C5–C
bond has been established on the basis of half band width
(W1/2) values of C3-axial proton in the
1H NMR spectra of
compounds 4 and 5 which clearly suggested that A/B ring junc-
tion is trans (Shamsuzzaman et al., 2013c) and also on the basis
of the fact that during the reaction, the attack of the reagent
should be from (a) side which is less hindered, not from (b) side
which is more hindered due to the presence of a methyl group
at C10, hence the C5–C bond should be axial (a) and trans to
C10 methyl group (Shamsuzzaman et al., 2010). C19 values in
13C NMR are strongly dependent on the ring fusion stereo-
chemistry. In the synthesized compounds 4–6, C19 chemicalshift values were observed in the range of 16–19 ppm, which
is consistent with the values, obtained for trans steroids (Iida
et al., 2007). The mechanism for the formation of steroidal
2H-pyran derivatives 4–6 involves the Michael addition of
active methylene of ethyl acetoacetate to conjugated ketone
at the electrophilic alkene C, in nucleophilic addition type pro-
cess, which undergoes subsequent intramolecular cyclization to
provide the desired product (Scheme 2).
3.2. In vitro anticancer activity
Steroids with a, b-unsaturated ketone core gave the potency
against human cancer cell lines (Wang et al., 2011). With this
intuition, an attempt of synthesizing steroidal 2H-pyran deriv-
atives 4–6 from steroidal a, b-unsaturated ketones 1–3 was
made. The synthesized compounds were evaluated for antican-
cer activity toward human HeLa (cervical) and Jurkat
(leukemia) cancer cells. Doxorubicin (Dox) and 5-ﬂuorouracil
(5-Fu) were used as cytotoxic drugs of reference. The conver-
sion of the soluble yellowish MTT to the insoluble purple for-
mazan by active mitochondrial lactate dehydrogenase of living
cells has been used to develop an assay system for the measure-
ment of cell proliferation. Dose-dependent effects of steroidal
2H-pyranes 4–6 on cell viability of HeLa, Jurkat and PBMC
cell lines are given in Fig. 1.
The anticancer data given in Table 3 show that compounds
4–6 exhibited moderate to good activity while compound 6
elicited the better inhibitory activity (IC50 < 19 lM) against
both cell lines.
Interestingly, the IC50 values of compounds 4 and 6 were
close to each other, apparently indicating that the acetylation
did not increase the anticancer activity. This might be due to
the deacetylation of compound 4 by an esterase present indig-
enously in cells (Samanta et al., 2013). It is a noteworthy point
that the synthesized compounds 4–6 were found to be slightly
more active against HeLa. The synthesized compounds 4–6
were also tested with normal cell line (PBMC) during which
they were found slightly toxic, all the compounds showed
IC50 > 60 lM.
Figure 1 Dose-dependent effects of steroidal 2H-pyranes 4–6 on
cell viability of HeLa, Jurkat and PBMC cell lines. Data shown are
mean ± standard error of at least three independent experiments.
Table 3 The anticancer data of steroidal 2H-pyrans 4-6.
Compounds HeLa IC50 lmol L
1 Jurkat PBMC
4 18.5 ± 0.6 22.6 ± 0.1 67
5 20.2 ± 0.2 33.2 ± 0.4 65
6 14.21 ± 0.5 18.6 ± 0.6 64
Dox 4.1 ± 0.1 4.3 ± 0.4 -
5-Fu 8.1 ± 0.3 9.0 ± 0.6 -
Doxorubicin (Dox) and 5-ﬂuorouracil (5-Fu) are drugs of reference.
Table 4 The antioxidant activity data of steroidal 2H-pyrans
4-6a.
Compounds % inhibition
25 lg/mL 50 lg/mL 75 lg/mL 100 lg/mL
4 16.8 ± 0.2 23.7 ± 0.3 21.6 ± 0.6 24.5 ± 0.4
5 12.8 ± 0.4 13.6 ± 0.5 16.6 ± 0.8 21.9 ± 0.9
6 15.6 ± 0.2 19.7 ± 0.3 22.6 ± 0.2 25.5 ± 0.3
Standard 36.0 ± 0.3 37.0 ± 0.2 44.0 ± 0.3 50.0 ± 0.5
Controlb - - - -
a Values represent the mean ± standard error mean (SEM) of
three experiments.
b No inhibition, standard: ascorbic acid.
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The in vitro antioxidant activity and scavenging effects of ste-
roidal 2H-pyran derivatives 4–6 were evaluated by usingdifferent reactive species assay containing DPPH radical scav-
enging activity. The free radical scavenging activity of the syn-
thesized compounds was evaluated through their ability to
quench the DPPH using ascorbic acid as a reference. The
potencies for the antioxidant activity of compounds 4–6 to
the reference drug are shown in Table 4.
In general, all the synthesized compounds were less potent
than the reference. Among the synthesized compounds, com-
pounds 4 and 6 exhibited a slightly better antioxidant activity
than compound 5.
4. Conclusion
We have developed a green, facile, convenient and efﬁcient ap-
proach for the synthesis of new steroidal 2H-pyrans 4–6 from
steroidal a, b-unsaturated ketones 1–3 using chitosan as an
eco-friendly heterogeneous catalyst. The in vitro anticancer
screening showed the impressive behavior of compound 6 by
being more potent anticancer agent. The antioxidant screening
showed good antioxidant activity of compounds 4 and 6. The
present study showed that steroidal 2H-pyrans 4–6 can be used
for future development through modiﬁcation and derivatiza-
tion to design more potent and selective anticancer and antiox-
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